Cargando…

Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up

BACKGROUND/AIM: Considering its early bactericidal activity, isoniazid (H) is an important first-line agent in tuberculosis (TB) treatment. The aim of this study was to evaluate the treatment regimens and results of H-resistant pulmonary TB patients. MATERIALS AND METHODS: We retrospectively evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	ASLAN, Ayşe Feyza, ORTAKÖYLÜ, Mediha Gönenç, BAĞCI, Belma Akbaba, TOPRAK, Sezer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific and Technological Research Council of Turkey (TUBITAK) 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388119/ https://www.ncbi.nlm.nih.gov/pubmed/37476899 http://dx.doi.org/10.55730/1300-0144.5639

Ejemplares similares

Management of Polydrug-Resistant Tuberculosis
por: Ortakoylu, Mediha Gonenc, et al.
Publicado: (2023)

Value of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosis
por: Iliaz, Sinem, et al.
Publicado: (2014)

Benign Solitary Pulmonary Necrotic Nodules: How Effectively Does Pathological Examination Explain the Cause?
por: Urer, Halide Nur, et al.
Publicado: (2020)

Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in various lung diseases
por: Ortakoylu, Mediha Gonenc, et al.
Publicado: (2015)

Co-infection of COVID-19 and Tuberculosis
por: Kılıç, Lütfiye, et al.
Publicado: (2022)

Interferon-Inducible Protein-10 as a Marker to Detect Latent Tuberculosis Infection in Patients with Inflammatory Rheumatic Diseases
por: Ortakoylu, Mediha Gonenc, et al.
Publicado: (2022)

Association between active pulmonary tuberculosis and circulating microRNAs: a preliminary study from Turkey
por: KALAYCI YÜKSEK, Fatma, et al.
Publicado: (2021)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
por: Aruldhas, Blessed Winston, et al.
Publicado: (2019)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
por: Inbaraj, Leeberk Raja, et al.
Publicado: (2023)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
por: Jung, Jin Ah, et al.
Publicado: (2015)

Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis
por: Rivera, Juan Gonzalo Bardalez, et al.
Publicado: (2023)

The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
por: Lin, Huang-Shen, et al.
Publicado: (2016)

Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study
por: Min, Jinsoo, et al.
Publicado: (2022)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

A Retrospective Analysis of Isoniazid-Monoresistant Tuberculosis: Among Iranian Pulmonary Tuberculosis Patients
por: Varahram, Mohammad, et al.
Publicado: (2014)

Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
por: Borisov, Andrey S., et al.
Publicado: (2018)

Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
por: Taylor, Allan W., et al.
Publicado: (2013)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis
por: Stagg, H R, et al.
Publicado: (2016)

Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review
por: Shahid, Noor ul ain, et al.
Publicado: (2022)

Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB)
por: De Castro, N, et al.
Publicado: (2022)

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
por: van Beek, Stijn W., et al.
Publicado: (2021)

Isoniazid-Induced Psychosis in a Patient with Pulmonary Tuberculosis: A Case Report
por: Khanna, Shreshth, et al.
Publicado: (2023)

Transmission of Mycobacterium tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012
por: Bargman, Carolyn, et al.
Publicado: (2013)

Correction to: Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB)
Publicado: (2022)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Long term effects of mild severity COVID‑19 on right ventricular functions
por: Akkaya, Fatih, et al.
Publicado: (2021)

Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda
por: Micheni, Lisa Nkatha, et al.
Publicado: (2021)

Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
por: van Beek, Stijn W., et al.
Publicado: (2021)

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
por: Pillay, Samantha, et al.
Publicado: (2022)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Isoniazid-induced liver disorder in the treatment of tuberculosis
por: Sivannan, Srinivasan, et al.
Publicado: (2018)

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis
por: Sarma, G. R. K.
Publicado: (2022)

Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study
por: Şahin, Füsun, et al.
Publicado: (2019)

High Isoniazid Resistance Rates in Rifampicin Susceptible Mycobacterium tuberculosis Pulmonary Isolates from Pakistan
por: Fasih, Naima, et al.
Publicado: (2012)

Acute psychosis secondary to isoniazid in pediatric pulmonary tuberculosis: A case report and literature review
por: Alfawaz, Saleh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m3oj9f8iklpteuhra2jmuvijo1